Coronary artery disease Posts on Medivizor
Navigation Menu

Coronary artery disease Posts on Medivizor

5 Things You Probably Didn’t Know About Your Adrenal Glands

5 Things You Probably Didn’t Know About Your Adrenal Glands

Posted by on Mar 15, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 3 comments

The adrenal glands-which are also called suprarenal glands-are part of the endocrine system and are found on the top of each kidney. How the endocrine system hormones work Hormones secreted from glands of the endocrine system travel in the bloodstream to target cells. Target cells have receptors that are specific to each hormone. The hormones and receptors...

Read More

Is ticagrelor effective in people with multi-vessel coronary artery disease?

Posted by on Mar 5, 2018 in Coronary artery disease | 0 comments

In a nutshell This study examined the safety and effectiveness of ticagrelor (Brilinta) in patients with multi-vessel coronary disease (MVD) who had a previous heart attack. It was determined that ticagrelor reduced the risk of major adverse cardiac events (MACE), but increased the risk of certain types of bleeding. Some background Coronary...

Read More

Are second generation drug-eluting stents better than bare-metal stents?

Posted by on Mar 5, 2018 in Coronary artery disease | 0 comments

In a nutshell This study compared the safety and effectiveness of second generation drug eluting stents (DES) and bare-metal stents (BMS) in patients undergoing percutaneous coronary intervention (PCI). It was determined that second generation DES reduced the chances of experiencing a major adverse cardiac event (MACE).  Some background...

Read More

Effects of high platelet reactivity after percutaneous coronary intervention

Posted by on Mar 5, 2018 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effect of high platelet reactivity (HPR) on major adverse cardiac events (MACEs) in people who have undergone percutaneous coronary intervention (PCI). It was determined that people with HPR were more likely to have a MACE. Some background PCI (or angioplasty) is a non-surgical procedure where narrow or...

Read More

Can sodium tanshinone IIA sulfate reduce the risk of heart attacks?

Posted by on Feb 17, 2018 in Coronary artery disease | 0 comments

In a nutshell This study investigated whether sodium tanshinone IIA sulfate (STS) plus atorvastatin (Lipitor) would be more effective at lowering high-sensitivity C-reactive protein (hs-CRP) levels than atorvastatin alone. It was determined that the combination reduced hs-CRP levels more than atorvastatin alone. Some background Coronary artery...

Read More

Emergencies and Illness

Emergencies and Illness

Posted by on Jan 17, 2018 in Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Hodgkin's lymphoma, Hypertension, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 1 comment

After three hurricanes, flooding, fires and mudslides, and now severe cold and snow in the Deep South and throughout the country, the US has had its share of emergencies. Are you prepared? For people who rely on oxygen, who are on dialysis, have diabetes or other serious conditions, it is time to think about putting together some of the essentials.  What...

Read More

Benefits and risks of adding clopidogrel to aspirin therapy

Posted by on Jan 15, 2018 in Coronary artery disease | 0 comments

In a nutshell This study investigated the benefits and risks of adding clopidogrel (Plavix) to aspirin in people at high risk of getting heart disease or having a stroke, and in people who already have heart disease. It was determined that the combination reduced the risk of heart attacks and stroke, but had no effect on mortality, and increased the...

Read More

Is percutaneous coronary intervention effective in in patients with other conditions?

Posted by on Jan 8, 2018 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effect of percutaneous coronary intervention (PCI) on in-hospital mortality of patients who have had heart attacks. The effects of age, sex, type of heart attack, diabetes, and chronic kidney disease (CKD) were examined. It was determined that PCI reduced mortality in all groups. Some background PCI is an...

Read More

Accurate Blood Pressure Readings Are More Important Than Ever Before

Accurate Blood Pressure Readings Are More Important Than Ever Before

Posted by on Dec 5, 2017 in Blog, Coronary artery disease, Diabetes mellitus, Hypertension, Stroke | 2 comments

These new goals are based on a significant number of research studies but especially the SPRINT study.  This was a large investigation with more than 9000 patients over the age of 50 whose blood pressure measured higher than 130 mm Hg.  Participants also had at least one of these risk facts:  1) “Presence of clinical or subclinical cardiovascular...

Read More

Is angioplasty as safe as coronary artery bypass grafting in people with left main coronary artery disease?

Posted by on Nov 9, 2017 in Coronary artery disease | 0 comments

In a nutshell This study compared the safety of percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) to coronary artery bypass grafting (CABG) in patients with left main coronary artery disease (LMCAD). It determined that PCI and CABG were equally safe, mortality-wise. However, PCI was associated with more non-fatal heart attacks,...

Read More